Individuals may be responders or nonresponders to antiobesity drugs. According to Hamdy and colleagues, "if a patient's response to a weight loss medication is deemed effective (weight loss of 5% or more of body weight at 3 mo) and safe, it is recommended that the medication be continued. If deemed ineffective (weight loss less than 5% at 3 mo) or if there are safety or tolerability issues at any time, it is recommended that the medication be discontinued and alternative medications or referral for alternative treatment approaches be considered."
If this is not attained, the antiobesity drug should be stopped and alternative medications or referral for alternative treatment approaches be considered.
Learn more about pharmacologic approaches for obesity management.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Elif A. Oral, Evelyn S. Marienberg. Fast Five Quiz: Management of Obesity - Medscape - Dec 19, 2022.